These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37315249)

  • 1. [Efficacy and safety of the drug Cellex for the treatment of patients with cognitive impairment with chronic cerebral ischemia - results of a multicenter randomized double-blind placebo-controlled clinical trial].
    Shchukin IA; Koltsov IA; Fidler MS; Chubykin VI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(5):108-116. PubMed ID: 37315249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurometabolic therapy of mild cognitive impairment in patients with chronic cerebral ischemia].
    Antipenko EA; Shulyndin AV; Belyakov KM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(3):42-51. PubMed ID: 38529862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of Mexidol in patients with chronic brain ischemia and cognitive impairment of different age groups (results of sub-analysis of the international multicenter, randomized, double-blind, placebo-controlled study of sequential therapy in patients with chronic brain ischemia MEMO)].
    Zakharov VV; Tkacheva ON; Mkhitaryan EA; Fedin AI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11. Vyp. 2):73-80. PubMed ID: 36412160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Cognitive Impairment and the Role of Demographic Factors in Disease Progression: The Final Results of the Russian Observational Program "DIAMANT".
    Parfenov VA; Zhivolupov SA; Poverennova IE; Nesterova MV; Ushakova SE; Zhukova NG; Glazunov AB; Nikulina KV; Alexandrov MV; Lapatukhin VG; Zhestikova MG
    Eur Neurol; 2020; 83(6):591-601. PubMed ID: 33202402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO)].
    Fedin AI; Zakharov VV; Tanashyan MM; Chukanova EI; Madzhidova EN; Shchepankevich LA; Ostroumova OD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11):7-16. PubMed ID: 34932280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Observational study of the efficacy and safety of the drug Ampasse in patients with moderate cognitive impairment in chronic cerebral ischemia].
    Zhitkova YV; Gasparyan AA; Saihunov MV; Kiselev AV; Stovbun SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(10):75-80. PubMed ID: 37966443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of GABA
    Chabriat H; Bassetti CL; Marx U; Audoli-Inthavong ML; Sors A; Lambert E; Wattez M; Hermann DM;
    Lancet Neurol; 2020 Mar; 19(3):226-233. PubMed ID: 32085836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Integrative assessment of the effectiveness and safety of outpatient use of Picamilon].
    Danilov AB; Shindryaeva NN; Borodulina IV; Lunegov TD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(7):119-130. PubMed ID: 39113452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical efficacy and safety of Picamilon in patients with progressive chronic cerebral ischemia].
    Danilov AB; Shindryaeva NN; Borodulina IV; Lunegov TD; Kristeleva DA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(8):71-80. PubMed ID: 39269299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of evaluation of the effectiveness of the drug Cellex in patients with small vessel disease].
    Kamchatnov PR; Abusueva BA; Khanmurzaeva SB; Mityaeva EV; Chipova DT; Malashenkov ND
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(1):67-74. PubMed ID: 36719121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of Logacer in patients with chronic brain ischemia and moderate cognitive impairment: results of non-interventional clinical observation].
    Zakharov VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(6):93-99. PubMed ID: 35758953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive Impairment.
    Guekht A; Skoog I; Edmundson S; Zakharov V; Korczyn AD
    Stroke; 2017 May; 48(5):1262-1270. PubMed ID: 28432265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dynamics of recovery of cognitive deficit in patients in the early recovery period of ischemic stroke].
    Kotov SV; Borisova VA; Slyunkova EV; Isakova EV; Kiselev AV; Kotov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11):26-32. PubMed ID: 34932282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenetic therapy of cognitive impairment: results of a multicenter placebo-controlled clinical trial of the efficacy and safety of Miladean].
    Levin OS; Zakharov VV; Khacheva KK; Vladykin AL; Globenko AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(10):60-68. PubMed ID: 37966441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of moderate cognitive impairment in the early recovery period of ischemic stroke].
    Belova AN; Bogdanov EI; Voznyuk IA; Zhadnov VA; Kamchatnov PR; Kurushina OV; Maslova NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(5):33-39. PubMed ID: 34184475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of Mexidol in patients with mild (moderate) cognitive impairment: results of a meta-analysis].
    Zakharov VV; Vakhnina NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(1):82-88. PubMed ID: 38261288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of the safety and clinical efficacy of the Brainmax in therapy of non-demented patients with a mild cognitive impairment].
    Ekusheva EV; Voitenkov VB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(2):83-89. PubMed ID: 36843463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.